There is no generic version of Benlysta (belimumab), a drug used to treat systemic lupus erythematosus (SLE), the most common form of the autoimmune disease lupus. Benlysta is currently protected by patent, and no generic version can be sold until the patent expires.
There is no generic version of Benlysta (belimumab), a drug used to
treat systemic lupus erythematosus (SLE), the most common form of
the autoimmune disease lupus. Benlysta is currently protected by
patent, and no generic version can be sold until...
More